These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 32690640)

  • 1. Safety and Pharmacokinetics of Recombinant Human Plasma Gelsolin in Patients Hospitalized for Nonsevere Community-Acquired Pneumonia.
    Tannous A; Levinson SL; Bolognese J; Opal SM; DiNubile MJ
    Antimicrob Agents Chemother; 2020 Sep; 64(10):. PubMed ID: 32690640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adjunctive Recombinant Human Plasma Gelsolin for Severe Coronavirus Disease 2019 Pneumonia.
    DiNubile MJ; Parra S; Salomó AC; Levinson SL
    Open Forum Infect Dis; 2022 Aug; 9(8):ofac357. PubMed ID: 35928505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant Human Plasma Gelsolin Improves Survival and Attenuates Lung Injury in a Murine Model of Multidrug-Resistant
    DiNubile MJ; Levinson SL; Stossel TP; Lawrenz MB; Warawa JM
    Open Forum Infect Dis; 2020 Aug; 7(8):ofaa236. PubMed ID: 32766380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low Admission Plasma Gelsolin Concentrations Identify Community-acquired Pneumonia Patients at High Risk for Severe Outcomes.
    Self WH; Wunderink RG; DiNubile MJ; Stossel TP; Levinson SL; Williams DJ; Anderson EJ; Bramley AM; Jain S; Edwards KM; Grijalva CG
    Clin Infect Dis; 2019 Sep; 69(7):1218-1225. PubMed ID: 30561561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant human plasma gelsolin (rhu-pGSN) in a patient hospitalized with critical COVID-19 pneumonia.
    Catteeuw JV; DiNubile MJ
    Clin Infect Pract; 2021 Nov; 12():100088. PubMed ID: 34396087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delayed Administration of Recombinant Plasma Gelsolin Improves Survival in a Murine Model of Penicillin-Susceptible and Penicillin-Resistant Pneumococcal Pneumonia.
    Yang Z; Bedugnis A; Levinson S; Dinubile M; Stossel T; Lu Q; Kobzik L
    J Infect Dis; 2019 Sep; 220(9):1498-1502. PubMed ID: 31287867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed administration of recombinant plasma gelsolin improves survival in a murine model of severe influenza.
    Yang Z; Bedugnis A; Levinson S; DiNubile M; Stossel T; Lu Q; Kobzik L
    F1000Res; 2019; 8():1860. PubMed ID: 31824672
    [No Abstract]   [Full Text] [Related]  

  • 8. Plasma gelsolin improves lung host defense against pneumonia by enhancing macrophage NOS3 function.
    Yang Z; Chiou TT; Stossel TP; Kobzik L
    Am J Physiol Lung Cell Mol Physiol; 2015 Jul; 309(1):L11-6. PubMed ID: 25957291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma gelsolin modulates the production and fate of IL-1β-containing microparticles following high-pressure exposure and decompression.
    Bhopale VM; Ruhela D; Brett KD; Nugent NZ; Fraser NK; Levinson SL; DiNubile MJ; Thom SR
    J Appl Physiol (1985); 2021 May; 130(5):1604-1613. PubMed ID: 33764168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CAL02, a novel antitoxin liposomal agent, in severe pneumococcal pneumonia: a first-in-human, double-blind, placebo-controlled, randomised trial.
    Laterre PF; Colin G; Dequin PF; Dugernier T; Boulain T; Azeredo da Silveira S; Lajaunias F; Perez A; François B
    Lancet Infect Dis; 2019 Jun; 19(6):620-630. PubMed ID: 31056427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent depletion of plasma gelsolin (pGSN) after exposure of mice to heavy silicon ions.
    Rithidech KN; Reungpatthanaphong P; Tungjai M; Jangiam W; Honikel L; Whorton EB
    Life Sci Space Res (Amst); 2018 May; 17():83-90. PubMed ID: 29753417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma gelsolin levels are associated with diabetes, sex, race, and poverty.
    Noren Hooten N; Mode NA; Kowalik E; Omoniyi V; Zonderman AB; Ezike N; DiNubile MJ; Levinson SL; Evans MK
    J Transl Med; 2023 Mar; 21(1):190. PubMed ID: 36899335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FOCUS 1: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    File TM; Low DE; Eckburg PB; Talbot GH; Friedland HD; Lee J; Llorens L; Critchley IA; Thye DA;
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii19-32. PubMed ID: 21482566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma gelsolin and circulating actin correlate with hemodialysis mortality.
    Lee PS; Sampath K; Karumanchi SA; Tamez H; Bhan I; Isakova T; Gutierrez OM; Wolf M; Chang Y; Stossel TP; Thadhani R
    J Am Soc Nephrol; 2009 May; 20(5):1140-8. PubMed ID: 19389844
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low Plasma Gelsolin Concentrations in Chronic Granulomatous Disease.
    Audley J; Gliniewicz EF; Zarember KA; Hong HS; Wald G; Kuhns DB; Kang E; Malech HL; Suffredini AF; Noveck RJ; Dinubile MJ; Levinson SL; Stossel TP; Gallin JI
    Inflammation; 2021 Feb; 44(1):270-277. PubMed ID: 32886268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma gelsolin depletion and circulating actin in sepsis: a pilot study.
    Lee PS; Patel SR; Christiani DC; Bajwa E; Stossel TP; Waxman AB
    PLoS One; 2008; 3(11):e3712. PubMed ID: 19002257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOCUS 2: a randomized, double-blinded, multicentre, Phase III trial of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in community-acquired pneumonia.
    Low DE; File TM; Eckburg PB; Talbot GH; David Friedland H; Lee J; Llorens L; Critchley IA; Thye DA;
    J Antimicrob Chemother; 2011 Apr; 66 Suppl 3():iii33-44. PubMed ID: 21482568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Plasma gelsolin level and its relationship with the prognosis of patients with severe burns].
    Huang LF; Yao YM; Dong N; He LX; Zhang QH; Yu Y; Sheng ZY
    Zhonghua Shao Shang Za Zhi; 2013 Apr; 29(2):148-51. PubMed ID: 23985203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Gelsolin and Its Association with Mortality and Hospitalization in Chronic Hemodialysis Patients.
    Flores Gama C; Rosales LM; Ouellet G; Dou Y; Thijssen S; Usvyat L; Zhang H; Kuntsevich V; Levin NW; Kotanko P
    Blood Purif; 2017; 43(1-3):210-217. PubMed ID: 28114138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma gelsolin: a general prognostic marker of health.
    Peddada N; Sagar A; Ashish ; Garg R
    Med Hypotheses; 2012 Feb; 78(2):203-10. PubMed ID: 22082609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.